Status | Study |
Recruiting |
Study Name: CMV-CTL for the Treatment of CMV Infection After HSCT Condition: Cytomegalovirus Infections Hematological Disease Date: 2016-12-18 Interventions: Biological: CMV-CTL donor deri |
Recruiting |
Study Name: Preemptive Adoptive CMV-CTL Infusion to Prevent Refractory CMV Infection Post Haplo-HSCT Condition: CMV Infection Date: 2016-11-28 Interventions: Biological: Donor-derived CMVpp65-specific T cells About 1 million per kg CMVpp65-specific T cells will |
Terminated |
Study Name: Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study Condition: CMV Infection Date: 2016-03-23 |
Enrolling by invitation |
Study Name: Screening for Congenital Cytomegalovirus Infection in Newborns Condition: Cytomegalovirus Infections Date: 2016-02-11 Interventions: Other: Observation Viable Infants with a failed hearing screen or a diagnosis of SGA who are born at eit |
Recruiting |
Study Name: Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence Condition: Cytomegalovirus Infections Date: 2016-01-26 Interventions: Drug: Drug conversion to sirolimus |
Recruiting |
Study Name: Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy Condition: Cytomegalovirus Infections Date: 2015-10-23 Interventions: Other: Blood draw and MRI The study is observational. The treatment-plan of the underlying disease remai |
Terminated |
Study Name: SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients Condition: Cytomegalovirus Disease Date: 2015-05-07 Interventions: Drug: Brincidofovir Other Name |
Recruiting |
Study Name: Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A Condition: Transplantation Infection Cytomegalovirus Infection Date: 2014-09-01 Interventions: Drug: Everolimus |
Active, not recruiting |
Study Name: A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. Condition: Transplant Recipients With CMV Infection Date: 2014-02-14 Interventions: Biological: CMV Infection Routine follow-up (viral load, creatininaemia, neutrophil count, isolation of |
Completed |
Study Name: A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients Condition: Cytomegalovirus Infections Date: 2012-12-17 Interventions: Drug: MCMV3068A Four doses of |